Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Atrial natriuretic peptide promotes uterine decidualization and a TRAIL-dependent mechanism in spiral artery remodeling
Wei Zhang, … , Ningzheng Dong, Qingyu Wu
Wei Zhang, … , Ningzheng Dong, Qingyu Wu
Published September 2, 2021
Citation Information: J Clin Invest. 2021;131(20):e151053. https://doi.org/10.1172/JCI151053.
View: Text | PDF
Research Article Vascular biology

Atrial natriuretic peptide promotes uterine decidualization and a TRAIL-dependent mechanism in spiral artery remodeling

  • Text
  • PDF
Abstract

Atrial natriuretic peptide (ANP) is an important hormone in cardiovascular biology. It is activated by the protease corin. In pregnancy, ANP and corin promote uterine spiral artery remodeling, but the underlying mechanism remains unknown. Here we report an ANP function in uterine decidualization and TNF-related apoptosis-inducing ligand–dependent (TRAIL-dependent) death in spiral arterial smooth muscle cells (SMCs) and endothelial cells (ECs). In ANP- or corin-deficient mice, uterine decidualization markers and TRAIL expression were decreased, whereas in cultured human endometrial stromal cells (HESCs), ANP increased decidualization and TRAIL expression. In uterine spiral arteries from pregnant wild-type mice, SMC and EC loss occurred sequentially before trophoblast invasion. In culture, TRAIL from decidualized HESCs induced apoptosis in uterine SMCs, but not in ECs with low TRAIL receptor expression. Subsequently, cyclophilin B was identified from apoptotic SMCs that upregulated endothelial TRAIL receptor and caused apoptosis in ECs. These results indicate that ANP promotes decidualization and TRAIL expression in endometrial stromal cells, contributing to sequential events in remodeling of spiral arteries, including SMC death and cyclophilin B release, which in turn induces TRAIL receptor expression and apoptosis in ECs.

Authors

Wei Zhang, Shuo Li, Jinglei Lou, Hui Li, Meng Liu, Ningzheng Dong, Qingyu Wu

×

Figure 5

SMC-derived cyclophilin B upregulates TRAIL receptor in uterine ECs.

Options: View larger image (or click on image) Download as PowerPoint
SMC-derived cyclophilin B upregulates TRAIL receptor in uterine ECs.
(A)...
(A) HUtMECs were incubated with control (Ctr) medium, or CM from SMCs without or with pretreatment of CM from HESCs or dHESCs in the presence (+) or absence (–) of binimetinib (Binim; 1 μM) for 48 hours. TRAIL-R1 and -R2 were analyzed by Western blotting. (B) Western blotting of TRAIL-R1 and -R2 in HUtMECs treated with unfractionated (Total) or fractionated CM with proteins of different molecular masses. (C) Cyclophilin B (CyPB) was depleted with an antibody (Ab) from SMC-derived CM. Western blotting was done for TRAIL-R1 and -R2 in HUtMECs treated with SMC-derived CM with (+) or without (–) CyPB depletion. (D) Western blotting of TRAIL-R1 and -R2 in HUtMECs treated with recombinant CyPB for 48 hours. (E and F) Uterine SMCs were treated with Ctr medium or CM from HESCs or dHESCs (E) or recombinant TRAIL (100 nM) (F) for 24 hours. Western blotting was done to examine CyPB in the CM (top) and cell lysates (bottom). Ponceau S–stained albumin in CM and GAPDH in lysates were controls. (G and H) Western blotting of phosphorylated (p) and total p44/42 MAPK in HUtMECs treated with recombinant CyPB (G) or different CM (H). (I) Western blotting of CyPB in non-pregnant (NP) and pregnant (GD12.5) uteri from WT mice. (J) CyPB staining in uterine sections from GD12.5-WT mice. Isotype-matched immunoglobulin (Ig) was a control (n = 3 per group). Selected areas of top panels (original magnification, ×40) are shown in lower panels (original magnification, ×400). Data are representative of at least 3 experiments.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts